Skip to content

U.S. weight loss supplement market surges

The weight loss supplement market is rapidly growing due to rising obesity and health awareness, with North America accounting for over 40% of the global market.

Photo by Supliful - Supplements On Demand / Unsplash

AUSTIN, Texas — The U.S. weight loss supplement market is expanding rapidly, driven by rising obesity rates, heightened health awareness, and growing demand for personalized weight management programs, according to a new report from DataM Intelligence. The global market, valued at nearly $29 billion in 2023, is projected to exceed $108 billion by 2033, growing at a compound annual growth rate (CAGR) of 14.1%.

North America continues to lead with a market share of more than 40%, supported by a health-conscious population and robust retail distribution. Major U.S. players, including CVS, GNC, and Amazon, have recently expanded their supplement assortments with products featuring cleaner labels and natural ingredients. Leading brands such as Herbalife, MuscleTech, and Nature’s Bounty are pairing supplement bundles with digital health apps and coaching programs, signaling a shift toward integrated, holistic weight management.

Fat burners and powders dominate demand

Fat burners account for nearly half of the U.S. market, as consumers seek products that boost their metabolism and energy levels. PhenQ, one of the top over-the-counter options, has recently earned endorsements from over 800 healthcare professionals.

Powders, with a nearly 38% share, also remain popular due to their flexible dosing and nutrient absorption. Abbott’s PROTALITY protein-rich shake, launched in 2024, has gained traction as a dual solution for weight loss and muscle health.

U.S. market shifts toward medication-backed programs

The market is also being reshaped by new approaches that combine behavioral coaching with pharmaceutical treatments. Noom, known for its digital weight loss platform, has introduced Noom Med, which incorporates anti-obesity medications such as Wegovy into personalized programs. This development marks a turning point, with medications playing a more prominent role in U.S. weight management strategies.

Key players and new launches

  • Abbott, Herbalife, Amway, Iovate Health Sciences, and Nature’s Bounty remain major players.
  • Cellev8 Nutrition recently launched SlimCell, a gummy formulated for post-GLP-1 support.
  • Lemme, the supplement brand founded by Kourtney Kardashian, has introduced an “all-natural” GLP-1 supplement, tapping into the same hormone pathway targeted by popular weight loss drugs.

To find out more, visit https://www.datamintelligence.com/ 

Latest